COVID-19 MRNA VACCINE DEVELOPMENT PROGRAM: FIRST PARTICIPANTS IN THE U.S.
May 8, 2020
First participants dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine. Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021
Links to sites outside of Pfizer Medical Information are provided as a resource to the viewer. This third-party website is neither owned nor controlled by Pfizer, and Pfizer does not endorse and is not responsible for the content or services of this site